AstraZeneca Stock Dips On Surprise Miss For Gilead-Rivaling Cancer Drug

byiShook Opinion
Sep 23, 2024 - 13:05

Share

AstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast cancer. The post AstraZeneca Stock Dips On Surprise Miss For Gilead-Rivaling Cancer Drug appeared first on Investor's Business Daily.

AstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast cancer.

The post AstraZeneca Stock Dips On Surprise Miss For Gilead-Rivaling Cancer Drug appeared first on Investor's Business Daily.